Search

WAIMR signs biotech deal with Proteomics International

The Western Australian Institute for Medical Research (WAIMR) has signed a new management deal with Perth-based company Proteomics International.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/06/18

1 year TSR5 year TSR
293rdProteomics International Laboratories29%0%
547thOrthocell-11%0%
643rdEphraim Resources-28%2%
750thResApp Health-54%132%
722 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

16/04/18
$0 Other
16/04/18
$0 Other
06/04/18
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

130th↓Proteomics International Laboratories$1.8m
143rd-MOKO Social Media$1.2m
144th↑ResApp Health$1.1m
146th↑Ephraim Resources$1.1m
148th↓Orthocell$1.0m
239 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Proteomics International Laboratories

366thRichard Lipscombe$325k
1085thJohn Dunlop$67k
1159thTerry Sweet$55k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer